Author(s):
Shashank Lavkush Shukla, Sudarshan E. Behere
Email(s):
vedants175@gmail.com , sudarshanbehere22@gmail.com
DOI:
10.52711/2231-5659.2024.00059 
Address:
Shashank Lavkush Shukla, Prof. Sudarshan E. Behere
Département of Pharmacology, JSPM Sudhakarrao Naik Institute of Pharmacy, Pusad, Dist. Yavatmal, Maharashtra 445204, India.
*Corresponding Author
Published In:
Volume - 14,
Issue - 4,
Year - 2024
ABSTRACT:
The use of N-nitrosamines, especially in the médical field, raises questions regardant global safety due to their hazardous and mutational properties. This comprehensive review looks at the technology, management, analysis, and biological consequences of nitrosamines in medical, pharmaceutical, and analgesic applications. This review discusses the atomic dangers associated with N-nitroso compounds, specifically focusing on DNA damage, DNA mutation, cancer prevention, and other related effects. Concerns about nitrosamine risk, the development of nitrosamine-free products, the importance of risk assessment, and diagnostic methods are also highlighted. A comprehensive review will benefit professionals working to lessen the harm caused by nitrosamines and improve the safety of medications, such as biologists, doctors, manufacturers, scientists, and engineers. The permissible limit for N-nitrosamine has been exceeded in clinics. Drug shortages resulted from the withdrawal or discontinuation of the anti-diabetic medication rifampicin and the medication metformin. Regrettably, the amines N in items also impede the creation of novel medications. Because of nitrogen dioxide damage, government bodies prohibit the use of a drug called in human drug relationship (DDI) investigations. One of the primary medications used in these investigations is rifampin. Drug makers are now compelled to act.
Cite this article:
Shashank Lavkush Shukla, Sudarshan E. Behere. Création of Medicinal Substance-Related Nitrosamine Exposerai Contaminants in Therapeutics. Asian Journal of Research in Pharmaceutical Sciences. 2024; 14(4):373-0. doi: 10.52711/2231-5659.2024.00059
Cite(Electronic):
Shashank Lavkush Shukla, Sudarshan E. Behere. Création of Medicinal Substance-Related Nitrosamine Exposerai Contaminants in Therapeutics. Asian Journal of Research in Pharmaceutical Sciences. 2024; 14(4):373-0. doi: 10.52711/2231-5659.2024.00059 Available on: https://ajpsonline.com/AbstractView.aspx?PID=2024-14-4-7
REFERENCES:
1. Study the influence of Mutagenic Treatment on Cell Suspension Culture of Elephantopus scaber L. for the Quantitative enhancement of Bioactive constituents and their Antioxidant potentials.
2. Lupeol Induced Apoptosis in Human Lung Cancer Cell Line: A Flow Cytometry Study. Lupeol Induced Apoptosis in Human Lung Cancer Cell Line: A Flow Cytometry Study.
3. Quality Improvement Methodologies in Pharmaceutical Manufacturing
4. A Brief Review on Genotoxic impurities in Pharmaceuticals.
5. Florian, J.; Matta, M. K.; DePalma, R.; Gershuny, V.; Patel, V.; Hsiao, C.-H.; Zusterzeel, R.; Rouse, R.; Prentice, K.; Nalepinski, C. G.; Kim, I.; Yi, S.; Zhao, L.; Yoon, M.; Selaya, S.; Keire, D.; Korvick, J.; Strauss, D. G. Effect of Oral Ranitidine on Urinary Excretion of Nitrosodimethylamine (NDMA): A Randomized Clinical Trial. JAMA. 2021; 326 (3): 240−249.
6. Phytoremediation Techniques.
7. Rutin Imparts Attenuation of Methyl Parathion-Induced Base-pair substitution.
8. Bharate, S. S. Critical Analysis of Drug Product Recalls Due to Nitrosamine Impurities. J. Med. Chem. 2021, 64 (6), 2923−2936.
9. Bharate S. Critical Analysis of Drug Product Recalls due to Nitrosamine Impurities.
10. Burns, M. J.; Teasdale, A.; Elliott, E.; Barber, C. G. Controlling a Cohort: Use of Mirabilis-Based Purge Calculations to Understand Nitrosamine-Related Risk and Control Strategy Options. Org. Process Res. Dev. 2020; 24 (8): 1531−1535.
11. Ashworth, I. W.; Curran, T. T.; Ford, J. G.; Tomasi, S. Prediction of N-Nitrosamine Partition Coefficients for Derisking Drug Substance Manufacturing Processes. Org. Process Res. Dev. 2021; 25 (4): 871−883.
12. Tabrez Shaikh, Amit Gosar, Hussain Sayyed. Nitrosamine Impurities in Drug Substances and Drug Products. Journal of Advances in Pharmacy Practices. 2020; 2(1): 48–57. http://doi.org/10.5281/zenodo.362909.
13. Vyas A., Godhaniya J., Patel A., Patel A., Patel N., Chudasama A., Shah S. A Review on Carcinogenic Impurities Found in Marketed Drugs and Strategies for its Determination by Analytical Methods. Asian Journal of Pharmaceutical Analysis. 2021; 11(2): 159-169. doi: 10.52711/2231-5675.2021.00028.
14. Identification of Impurities and Degradation Products in Pharmaceutical Products- Role of Hyphenated Techniques.
15. A Review on Carcinogenic Impurities Found in Marketed Drugs and Strategies for its Determination by Analytical Methods
16. Akkaraju, H.; Tatia, R.; Mane, S. S.; Khade, A. B.; Dengale, S. J. A Comprehensive Review of Sources of Nitrosamine Contamination of Pharmaceutical Substances and Products. Regul. Toxicol. Pharmacol. 2023; 139: 105355.
17. Holzgrabe, U. Nitrosated Active Pharmaceutical Ingredients -Lessons Learned? J. Pharm. Sci. 2023; 112: 1210.
18. Tuesuwan, B.; Vongsutilers, V. Current Threat of Nitrosamines in Pharmaceuticals and Scientific Strategies for Risk Mitigation. J.Pharm. Sci. 2023; 112: 1192.
19. A Review on Metal Impurities in Pharmaceuticals
20. Stress and Quality of Life among Breast Cancer Patients.
21. Review on Guideline on Elemental Impurities
22. Fast LC Method for Determination of Cefditoren Pivoxil and Its Related Impurities in Bulk and Pharmaceutical Formulations
23. Separation, Identification and Quantification of process related Impurities and Stress Degradants of Gefitinib by LC-ESI-Q–TOF/M.
24. A Review on Carcinogenic Impurities Found in Marketed Drugs and Strategies for its Determination by Analytical Methods
25. Herbs used in Skin Protection from Ultravoilet Sun Radiation.
26. A Review on Carcinogenic Impurities Found in Marketed Drugs and Strategies for its Determination by Analytical Methods
27. Shaik K, Sarmah B, Wadekar G, Kumar P. Regulatory Updates and Analytical Methodologies for Nitrosamine Impurities Detection in Sartans, Ranitidine, Nizatidine, and Metformin along with Sample Preparation Techniques. Critical Reviews in Analytical Chemistry. 2020. doi: https://doi.org/10.1080/10408347.2020.1788375
28. A Novel RP-Chiral Separation Technique for the Quantification of Brivaracetam and its process Related Isomeric Impurities using High Performance Liquid Chromatography.
29. European Pharmacopeia, Trolamine Monograph, Edition 10.5. Council of Europe: Strasbourg, 2021.
30. A Brief Review on Genotoxic impurities in Pharmaceuticals.
31. Insight into Analytical Techniques for the Detection of Nitrosamine Impurities: A Review.
32. The Quantitative Determination of Process Related Genotoxic Impurities in Esomeprazole Magnesium by GC-MS.
33. Determination, Method Development and Validation of Six Nitrosamine Impurities in Purified water by using LC-MS/MS.